Evidence map›Paper›PMID 30926165›Full record

ArticleBiochemical and biophysical research communications2019

Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation.

Megan R Showalter, Benjamin Wancewicz, Oliver Fiehn, Joehleen A Archard, Shannon Clayton, Joseph Wagner, Peter Deng, Julian Halmai, Kyle D Fink, Gerhard Bauer and 9 more

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Exosome: an overview on enhanced biogenesis by small molecules.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Megan R ShowalterWest Coast Metabolomics Center, University of California Davis, USA.
Benjamin WancewiczWest Coast Metabolomics Center, University of California Davis, USA.
Oliver FiehnWest Coast Metabolomics Center, University of California Davis, USA.
Joehleen A ArchardDepartment of Otolaryngology, University of California Davis, USA.
Shannon ClaytonDepartment of Otolaryngology, University of California Davis, USA.
Joseph WagnerDrug Discovery Consortium, University of California, USA.
Peter DengDepartment of Neurology, University of California Davis, USA.
Julian HalmaiDepartment of Neurology, University of California Davis, USA.
Kyle D FinkDepartment of Neurology, University of California Davis, USA.
Gerhard BauerGood Manufacturing Practice Facility, University of California Davis, USA.
Brian FuryGood Manufacturing Practice Facility, University of California Davis, USA.
Nicholas H PerottiGood Manufacturing Practice Facility, University of California Davis, USA.
Michelle AppersonDepartment of Neurology, University of California Davis, USA.
Janelle ButtersDepartment of Neurology, University of California Davis, USA.
Peter BelafskyDepartment of Otolaryngology, University of California Davis, USA.
Gregory FarwellDepartment of Otolaryngology, University of California Davis, USA.
Maggie KuhnDepartment of Otolaryngology, University of California Davis, USA.
Jan A NoltaStem Cell Program, University of California Davis, USA.
Johnathon D AndersonDepartment of Otolaryngology, University of California Davis, USA. Electronic address: joanderson@ucdavis.edu.

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Institutional Career Development Core (KL2)KL2TR001859 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HOLMES, JAMES F. · 2016 to 2025
$10.1M
Training Program In Basic & Translational Cardiovascular ScienceT32HL086350 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Martin Cadeiras, David A. Liem · 2008 to 2026
$7.1M
West Coast Metabolomics Center for Compound IdentificationU2CES030158 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2018 to 2021
$4.1M
Direct cell to cell transfer of microRNA for tissue repairR01GM099688 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NOLTA, JAN A. · 2011 to 2015
$2.7M
Training Program in Biomolecular TechnologyT32GM008799 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI LEACH, J. KENT · 2002 to 2016
$2.4M
Predoctoral Training in Pharmacological SciencesT32GM099608 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2012 to 2021
$2.2M
NCATS NIH HHS KL2 TR001859NCATS NIH HHS UL1 TR001860NCI NIH HHS P30 CA093373NHLBI NIH HHS T32 HL086350NIEHS NIH HHS U2C ES030158NIGMS NIH HHS R01 GM099688NIGMS NIH HHS T32 GM008799NIGMS NIH HHS T32 GM099608
6 · The paper itself

Abstract

Mesenchymal stem cell (MSC) based therapies are currently being evaluated as a putative therapeutic in numerous human clinical trials. Recent reports have established that exosomes mediate much of the therapeutic properties of MSCs. Exosomes are nanovesicles which mediate intercellular communication, transmitting signals between cells which regulate a diverse range of biological processes. MSC-derived exosomes are packaged with numerous types of proteins and RNAs, however, their metabolomic and lipidomic profiles to date have not been well characterized. We previously reported that MSCs, in response to priming culture conditions that mimic the in vivo microenvironmental niche, substantially modulate cellular signaling and significantly increase the secretion of exosomes. Here we report that MSCs exposed to such priming conditions undergo glycolytic reprogramming, which homogenizes MSCs' metabolomic profile. In addition, we establish that exosomes derive from primed MSCs are packaged with numerous metabolites that have been directly associated with immunomodulation, including M2 macrophage polarization and regulatory T lymphocyte induction.

Indexed as

Cell LineExosomesGlycolysisHumansImmunomodulationMacrophage ActivationMesenchymal Stem CellsMetabolomeT-Lymphocytes, RegulatoryExosomesLipidomicsMesenchymal stem cellsMetabolomics

Identifiers

PMID30926165
PMCPMC6682414

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.